J. O'Dea

Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens

S. Chang, T. Banks, D. Driver, 1997, Journal of virology.

Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens

S. Chang, T. Banks, M. Chen, 1997, Journal of virology.

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

S. Chang, P. Sheridan, T. Dubensky, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.

R. Eason, S. Mento, M. Sällberg, 1998, Human gene therapy.

Developing an automated robotic factory for novel stem cell therapy production.

Karen Twomey, Mary Murphy, Chiara Gentili, 2016, Regenerative medicine.